Utilization of In-capillary Nanoreactor: Inhibition Study of Cytochrome P450 2C9 Isoform Reaction with Diclofenac and Sulfaphenazole by Means of Capillary Electrophoresis

Investor logo
Investor logo

Warning

This publication doesn't include Faculty of Medicine. It includes Faculty of Science. Official publication website can be found on muni.cz.
Authors

ŘEMÍNEK Roman ZEISBERGEROVÁ Marta GLATZ Zdeněk

Year of publication 2012
Type Conference abstract
MU Faculty or unit

Faculty of Science

Citation
Description A new methodology for creation of nanoscale bioreactor inside the separation capillary in capillary electrophoresis was developed. In principle, solutions of reactants are injected by relatively low pressure as a series of consecutive narrow plugs with slightly parabolic profiles due to laminar nature of the hydrodynamic flow inside the capillary. Reaction mixture is then mixed by combination of longitudinal and transverse diffusion within minute period. This procedure provides homogenous reaction mixture with easily changeable composition. Kinetic and inhibition studies of cytochrome P450 2C9 (CYP2C9) reaction with diclofenac as a probe substrate and sulfaphenazole as a probe inhibitor were performed in order to prove the applicability of proposed methodology for on-line screenings of CYP2C9 inhibitors in early stages of a new drug development. As a result apparent Michaelis constant of 2.66 +- 0.18 uM, apparent maximum reaction velocity of 7.91 +- 0.22 nmol/min/nmol, Hill coefficient of 1.59 +- 0.16, 50 % inhibitory concentration of 0.94 +- 0.04 uM and apparent inhibition constant of 0.39 +- 0.07 uM were determined. All these values are in agreement with literature data obtained by different techniques. What is more, developed methodology enables reduction of CYP2C9 solution consumption to 0.6 nl per analysis.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info